Early-Stage Partner in Care Living Alone Plus
Launched by ARIZONA STATE UNIVERSITY · Apr 29, 2025
Trial Information
Current as of June 06, 2025
Recruiting
Keywords
ClinConnect Summary
The EPICLA+ trial, or Early-Stage Partners in Care Living Alone Plus, is a research project aimed at helping people with early memory loss, such as those with mild cognitive impairment or early-stage Alzheimer's disease, who live alone. The program offers educational sessions and skills training through Zoom, focusing on reducing stress, improving overall well-being, and helping participants manage daily challenges. Feedback from participants will be collected to continually enhance the program for those experiencing early memory issues.
To be eligible for this trial, participants must be at least 60 years old, live in the U.S., and speak either English or Spanish. They should also be able to provide consent and have a diagnosis of early-stage dementia or meet certain memory test scores. Participants will take part in online workshops and will need a stable internet connection to join. It’s important to note that individuals who are not comfortable using a computer or don’t want to participate may not be eligible. This program aims to create a supportive community for those navigating memory loss while living alone.
Gender
ALL
Eligibility criteria
- • Early-stage inclusion criteria
- • 1. Must be at least 60 years of age
- • 2. Must be able to participate in English or Spanish
- • 3. Must be a US resident
- • 4. Must be able to provide consent verbally and in writing (electronically or via mail)
- • 5. Must exhibit at least 2 of 8 changes caused by thinking and memory problems on the AD8 (a reliable and valid 8-item dementia screening tool).
- 6. The Early-stage individual must have a diagnosis of early-stage ADRD or have a Mini-Mental State Exam (MMSE) score:
- • 1. between 20-26 for those who have completed high school, or
- • 2. between 17-26\*, for those who have not completed high school, or
- • 3. 27 or higher with a confirmed diagnosis of early-stage dementia or MCI.
- • 7. Able to participate in EPIC-LA workshops via zoom
- Exclusion Criteria:
- • 8. Inability to participate via telephone or online video conferencing service.
- • 9. The participant expresses feelings of not wanting to participate
- • 10. The participant do not have enough time to attend the training,
- • 11. The participant demonstrates lack of skills with using a computer that precludes participation
- • 12. The participant does not have a stable internet connection to connect to the video platform
- • 13. The participant has difficulty hearing or a visual impairment that precludes participation.
About Arizona State University
Arizona State University (ASU) is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, ASU leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical research practices and collaboration with healthcare professionals, ASU strives to translate research findings into practical applications that benefit society. The university's focus on community engagement and real-world impact underscores its role as a pivotal player in the advancement of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Phoenix, Arizona, United States
Patients applied
Trial Officials
Dr. Gomez-Morales
Principal Investigator
ASU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported